Cargando…
Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial
BACKGROUND: Highly variable insulin sensitivity, susceptibility to hypoglycemia and inability to effectively communicate hypoglycemic symptoms pose significant challenges for young children with type 1 diabetes (T1D). Herein, outcomes during clinical MiniMed™ 670G system use were evaluated in childr...
Autores principales: | Forlenza, Gregory P., Ekhlaspour, Laya, DiMeglio, Linda A., Fox, Larry A., Rodriguez, Henry, Shulman, Dorothy I., Kaiserman, Kevin B., Liljenquist, David R., Shin, John, Lee, Scott W., Buckingham, Bruce A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons A/S
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304187/ https://www.ncbi.nlm.nih.gov/pubmed/35001477 http://dx.doi.org/10.1111/pedi.13312 |
Ejemplares similares
-
Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes
por: Forlenza, Gregory P., et al.
Publicado: (2019) -
Medtronic MiniMed 670G Hybrid Closed-Loop System
por: Knebel, Tory, et al.
Publicado: (2019) -
Medtronic MiniMed 670G Auto Mode: Implications for Clinical Practice
por: Dos Santos-Marinho, Jeanne, et al.
Publicado: (2021) -
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
por: Cordero, Toni L., et al.
Publicado: (2023) -
The Effectiveness of Virtual Training on the MiniMed™ 670G System in People with Type 1 Diabetes During the COVID-19 Pandemic
por: Vigersky, Robert A., et al.
Publicado: (2021)